BIA Separations is the leading developer of monolith technology and the exclusive producer of CIM® (convective interaction media) chromatographic columns for the production, purification, and analysis of large biomolecules.
Our ongoing mission is to develop and produce CIM® monolithic columns of the highest quality and provide superior research and method development services for our customers.
We will remain the world’s leader in chromatography innovation by combining the power of our CIM® monolithic technology with our accumulated knowledge in biomolecular separation and purification and our well-founded experience in the development and validation of analytical methods. We are subject matter experts with many years of combined knowledge and hands-on experience to tackle the diverse needs of our pharmaceutical and biotechnology customers today and in the future.
Supplying every customer with the best possible chromatography materials and methods is the intrinsic policy of BIA Separations. Our expertise in the production of CIM® monolithic columns and the purification and analysis of biomolecules guides our customers through the drug development, semi-preparative, and industrial-scale processes. We present tangible solutions that simplify and accelerate development and production, improve product quality, and decrease costs from lab through industrial-scale.
Exceptional customer service is the cornerstone of our business philosophy. BIA Separations offers robust purification products and techniques for the manufacture of large biomolecules and high-quality products, and we also like to be known for our ethical practices and exemplary reputation. We accomplish this by delivering the most accurate and honest answers to our customers to help forge long-lasting business relationships. Therefore, we are committed to handling all customer inquiries on the spot or within the first 24 hours.